A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International journal of pharmaceutics

• Publication date

  2011-10-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2011.07.012PMID 21787854
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

  2008cited by this paper
• PROCESS CONTROL PERSPECTIVE FOR PROCESS ANALYTICAL TECHNOLOGY: INTEGRATION OF CHEMICAL ENGINEERING PRACTICE INTO SEMICONDUCTOR AND PHARMACEUTICAL INDUSTRIES

  2007cited by this paper
• Tenofovir-induced kidney injury

  2007cited by this paper
• Recent advances with liposomes as pharmaceutical carriers

  2005cited by this paper
• The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol

  2005cited by this paper
• Intracellular Pharmacokinetics of Tenofovir Diphosphate, Carbovir Triphosphate, and Lamivudine Triphosphate in Patients Receiving Triple-Nucleoside Regimens

  2005cited by this paper
• Tenofovir‐Related Nephrotoxicity: Case Report and Review of the Literature

  2004cited by this paper
• Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures.

  2002cited by this paper
• Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults

  2001cited by this paper
• Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose.

  1997cited by this paper
• Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats.

  1996cited by this paper
• Stable positively charged liposome during long-term storage.

  1993cited by this paper
• Quality by design managing research and development

  1992cited by this paper
• Complementary molecular shapes and additivity of the packing parameter of lipids.

  1991cited by this paper
• Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

  1980cited by this paper
• Liposomes and their uses in biology and medicine.

  1978cited by this paper
• The carrier potential of liposomes in biology and medicine (second of two parts).

  1976cited by this paper
• Drug-carrier potential of liposomes in cancer chemotherapy.

  1974cited by this paper
• Biophysical properties of phospholipids. II. Permeability of phosphatidylserine liquid crystals to univalent ions.

  1966cited by this paper
• Diffusion of univalent ions across the lamellae of swollen phospholipids.

  1965cited by this paper
• YELLOW NAILS AND LYMPHOEDEMA.

  1964cited by this paper

• Implementing QbD for Nano-Pharmaceuticals and Complex Formulations to Achieve Predictable and High-Quality Outcomes

  2026cites this paper
• Bridging membrane fluidity studies with a predictive model of drug encapsulation to address industrial challenges of liposomal injectables manufacturing

  2025cites this paper
• Design and optimization of indomethacin-loaded solid dispersion orally dissolving films: Machine learning and molecular dynamics study.

  2025cites this paper
• Advancements in Pharmaceutical Lyophilization: Integrating QbD, AI, and Novel Formulation Strategies for Next-Generation Biopharmaceuticals

  2025cites this paper
• Blockchain-enabled quality by design system for clinical trials

  2025cites this paper
• Galactosylated liposomes for targeted encapsulation and enhanced cytotoxicity of Mistletoe Lectin, an antitumoral type 2 ribosome-inactivating protein

  2025cites this paper
• QbD-based Optimization of Stimuli-sensitive Nanoemulgel of Miconazole Nitrate for Safe and Effective Treatment of Oral Candidiasis

  2025cites this paper
• Roadmap for Commercial Nanomedicine Development: Integrating Quality by Design Principles with Pharmaceutical Nanotechnology.

  2025cites this paper
• Implementation of design of experiments in liposome manufacturing: ethanol injection and extrusion as a case study

  2025cites this paper
• INFLUENCE OF FORMULATION FACTORS ON THE EFFICIENCY OF PASSIVE LOADING OF GEMCITABINE INTO LIPOSOMES

  2025cites this paper
• Leveraging quality by design for the optimization of polycaprolactone/chitosan nanocomposites loaded with tamoxifen for breast cancer therapy.

  2025cites this paper
• Development and Optimization of Rutin-loaded Nanolipid Carrier for the Healing and Management of Diabetic Wound

  2025cites this paper
• Advances in Oral Solid Drug Delivery Systems: Quality by Design Approach in Development of Controlled Release Tablets

  2025cites this paper
• Structural and energetic properties of lecithin liposomes encapsulating coenzyme Q10 from coarse-grained simulations

  2024cites this paper
• Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus.

  2024cites this paper
• A remodeled ivermectin polycaprolactone-based nanoparticles for inhalation as a promising treatment of pulmonary inflammatory diseases.

  2024cites this paper
• Quality by design approach assisted development and optimization of Chitosan–Vildagliptin nanoparticles using a simple desolvation technique

  2024cites this paper
• A quality-by-design approach for optimizing the functionalization of gold nanoparticles onto the surface of doxorubicin-encapsulated liposomes.

  2024cites this paper
• Advanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone

  2024cites this paper
• A brief overview of quality by design approach for developing pharmaceutical liposomes as nano-sized parenteral drug delivery systems

  2024cites this paper
• Descriptive Review on Liposomal Drug Delivery System

  2024cites this paper
• Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends.

  2024cites this paper
• Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery

  2024cites this paper
• Development of invaethosomes and invaflexosomes for dermal delivery of clotrimazole: optimization, characterization and antifungal activity

  2023cites this paper
• Liposomes or Extracellular Vesicles: A Comprehensive Comparison of Both Lipid Bilayer Vesicles for Pulmonary Drug Delivery

  2023cites this paper
• Implementation of Quality by Design in the Formulation and Development of Nanocarrier-Based Drug Delivery Systems.

  2023cites this paper
• Efficiency of PGK1 proteins delivered to the brain via a liposomal system through intranasal route administration for the treatment of spinocerebellar ataxia type 3

  2023cites this paper
• Quality by design for the synthesis and optimisation of arginine-poly(ester-amide) nanocapsules as promising carriers for nose-brain delivery of carbamazepine

  2023cites this paper
• Development of Liposomal Encapsulated Silver Sulfadiazine Gel for Burn Therapy

  2023cites this paper
• Exploring novel and fast stability or sameness evaluation tool for different categories of Injectable formulations.

  2023cites this paper
• Potential of milk fat globule membrane’s phospholipids and anhydrous milk fat based nanostructured lipid carriers for enhanced bioaccessibility of vitamin D3

  2023cites this paper
• Crystal Engineering to Solidify and Chemically Stabilize Oily dl-Butylphthalide

  2023cites this paper
• INTEGRATED DESIGN METHODOLOGY: A PROPOSAL FOR A SCIENTIFIC RESEARCH-BASED DESIGN PROCESS FOR STIMULI-RESPONSIVE PRODUCTS

  2023cites this paper
• A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review

  2022cites this paper
• Medium and large scale preparation of Nanostructured Lipid Carriers of asenapine maleate: Quality-by-design based optimization, production, characterization and performance evaluation

  2022cites this paper
• Quality by Design (QbD) application for the pharmaceutical development process

  2022cites this paper
• Enhancement of antiproliferative potential of metformin against melanoma mice B16 cells using an optimized liposomal drug delivery system.

  2022cites this paper
• QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics

  2022cites this paper
• Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers

  2022cites this paper
• Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study

  2022cites this paper
• Regulatory Science Approach in Pharmaceutical Development of Follow-On Versions of Non-Biological Complex Drug Products.

  2022cites this paper
• Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach

  2022cites this paper
• Quality by Design Approach in Liposomal Formulations: Robust Product Development

  2022cites this paper
• Exploring microfluidics and membrane extrusion for the formulation of temozolomide-loaded liposomes: investigating the effect of formulation and process variables

  2022cites this paper
• Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application

  2022cites this paper
• Design and Scale-Up of Amorphous Drug Nanoparticles Production via a One-Step Anhydrous Continuous Process.

  2022cites this paper
• Machine Learning-Enabled NIR Spectroscopy in Assessing Powder Blend Uniformity: Clear-Up Disparities and Biases Induced by Physical Artefacts

  2022cites this paper
• Optimization of nanovesicular carriers of a poorly soluble drug using factorial design methodology and artificial neural network by applying quality by design approach

  2021cites this paper
• QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation

  2021cites this paper
• Preparation and characterization of bupivacaine multivesicular liposome: A QbD study about the effects of formulation and process on critical quality attributes.

  2021cites this paper
• Development and optimization of TPGS-based stealth liposome of doxorubicin using Box–Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells

  2021cites this paper
• Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration

  2021cites this paper
• Regulation of Nanotechnology-Based Products Subject to Health Regulations: Application of Quality by Design (QbD) and Quality Risk Management (QRM)

  2021cites this paper
• Formulation and In-vitro Characterization of Metformin Hydrochloride-loaded Liposomes

  2021cites this paper
• A Systematic, Knowledge Space-Based Proposal on Quality by Design-Driven Polymeric Micelle Development

  2021cites this paper
• Quality by design prospects of pharmaceuticals application of double emulsion method for PLGA loaded nanoparticles

  2021cites this paper
• Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol

  2021cites this paper
• Design and development of topical liposomal formulations in a regulatory perspective

  2021cites this paper
• Systematic development and characterization of inhalable dry powder containing Polymeric Lipid Hybrid Nanocarriers co-loaded with ABCB1 shRNA and docetaxel using QbD approach

  2021cites this paper
• A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy

  2021cites this paper
• Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19

  2021cites this paper
• Quality by Design: A Methodical Approach in Development of Nano Delivery System

  2021cites this paper
• Application of the QbD Approach in the Development of a Liposomal Formulation with EGCG

  2021cites this paper
• A full factorial experimental design to study the effect of flavoring agents on the mechanical properties of curcumin chewing gum tablets with high solids content

  2020cites this paper
• Applications of artificial intelligence in drug delivery and pharmaceutical development

  2020cites this paper
• Critical quality attributes in the development of therapeutic nanomedicines toward clinical translation

  2020cites this paper
• Enhancement of the Solubility of Rosuvastatin Calcium by Nanovesicular Formulation: A Systematic Study Based on a Quality by Design Approach

  2020cites this paper
• QbD based approach for formulation development of spray dried microparticles of erlotinib hydrochloride for sustained release

  2020cites this paper
• Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment

  2020cites this paper
• Phosphatidylserine (PS)- and phosphatidylglycerol-(PG)-enriched mixed micelles (MM): a new nano-drug delivery system with anti-inflammatory potential?

  2020cites this paper
• Application of Response Surface Optimization Methodology in Designing Ordispersible Tablets of Antdiabetic Drug

  2020cites this paper
• Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation

  2020cites this paper
• Development of a Curcumin-Loaded Polymeric Microparticulate Oral Drug Delivery System for Colon Targeting by Quality-by-Design Approach

  2020cites this paper
• Optimization and characterization of tannic acid loaded niosomes for enhanced antibacterial and anti-biofilm activities

  2020cites this paper
• Design of gadoteridol-loaded cationic liposomal adjuvant CAF01 for MRI of lung deposition of intrapulmonary administered particles.

  2019cites this paper
• Phosphatidylserine (Ps) and Phosphatidylglycerol (Pg) Nanodispersions as potential anti-inflammatory therapeutics: Comparison of In Vitro activity and impact of Pegylation.

  2019cites this paper
• Quality by Design in Pharmaceutical Manufacturing: a systematic review of current status, challenges and future perspectives.

  2019cites this paper
• NAG-PEGylated multilamellar liposomes for BBB-GLUT transporter targeting

  2019cites this paper
• QbD-Based Development of Pharmaceutical Parenteral Drug Products: An Overview

  2019cites this paper
• Nanoinformatics and biomolecular nanomodeling: a novel move en route for effective cancer treatment

  2019cites this paper
• Comprehensive quality by design approach for stable nanocrystalline drug products.

  2019cites this paper
• Application of Quality by Design Paradigms for Development of Solid Dosage Forms

  2019cites this paper
• Quality by Design Considerations for the Development of Lyophilized Products

  2019cites this paper
• Insulin Mucoadhesive Liposomal Gel for Wound Healing: a Formulation with Sustained Release and Extended Stability Using Quality by Design Approach

  2019cites this paper
• Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma

  2019cites this paper
• Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.

  2019cites this paper
• Pharmaceutical Development of Liposomes Using the QbD Approach

  2019influential citation
• Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin

  2019cites this paper
• Cyanosomes: A pilot study.

  2019cites this paper
• QbD Applications for the Development of Nanopharmaceutical Products

  2019cites this paper
• Comprehensive Study of Intermediate and Critical Quality Attributes for Process Control of High-Shear Wet Granulation Using Multivariate Analysis and the Quality by Design Approach

  2019cites this paper
• Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug

  2019cites this paper
• Developing cream formulations: renewed interest in an old problem.

  2019cites this paper
• Machine learning modelling of wet granulation scale-up using compressibility, compactibility and manufacturability parameters

  2019cites this paper
• QbD approached comparison of reaction mechanism in microwave synthesized gold nanoparticles and their superior catalytic role against hazardous nirto‐dye

  2019cites this paper
• Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design

  2018cites this paper
• Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach

  2018influential citation
• Optimizing liposomes for delivery of Bowman-Birk protease inhibitors - Platforms for multiple biomedical applications.

  2018cites this paper
• The significance of drug-to-lipid ratio to the development of optimized liposomal formulation

  2018influential citation
• In situ mucoadhesive‐thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin

  2018cites this paper